A study of nearly 1 million women followed over 18 years confirms that the HPV vaccine reduces cervical cancer risk by four times when administered before age 17. Researchers found the protection is long-lasting and does not appear to weaken nearly two decades after vaccination.
Read Full Article
#HPVvaccine #CervicalCancerPrevention #WomenHealth
Read Full Article
#HPVvaccine #CervicalCancerPrevention #WomenHealth
The BMJ
Extended follow-up of invasive cervical cancer risk after quadrivalent HPV vaccination: nationwide, register based study
Objectives To evaluate the long term risk of invasive cervical cancer after receiving the quadrivalent human papillomavirus (HPV) vaccine, how risk varies by time since vaccination, and to assess the population level impact of HPV vaccination programmes.…
Risk of dying from cervical cancer before 30 'close to zero' after HPV vaccine rollout - Children vaccinated at age 12–13 against HPV (human papillomavirus) have close to zero risk of dying from cervical cancer before the age of 30, landmark new research reveals.
Read Full Article
#HPVvaccine #CervicalCancerPrevention #PublicHealthScience
Read Full Article
#HPVvaccine #CervicalCancerPrevention #PublicHealthScience
Bbc
Risk of cervical cancer death before 30 'close to zero' after HPV vaccine
A new study finds that hundreds of lives have been saved since school-age girls were offered the HPV jab in 2008.
❤1🤡1🤨1